KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Equity (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Return on Equity for 10 consecutive years, with 1.86% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 141.0% year-over-year to 1.86%, compared with a TTM value of 1.86% through Sep 2025, up 141.0%, and an annual FY2024 reading of 0.58%, down 1.0% over the prior year.
  • Return on Equity was 1.86% for Q3 2025 at Medpace Holdings, up from 1.09% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.86% in Q3 2025 and bottomed at 0.2% in Q4 2021.
  • Average Return on Equity over 5 years is 0.58%, with a median of 0.51% recorded in 2024.
  • The sharpest move saw Return on Equity decreased -25bps in 2024, then skyrocketed 141bps in 2025.
  • Year by year, Return on Equity stood at 0.2% in 2021, then soared by 242bps to 0.67% in 2022, then dropped by -18bps to 0.55% in 2023, then decreased by -14bps to 0.47% in 2024, then skyrocketed by 292bps to 1.86% in 2025.
  • Business Quant data shows Return on Equity for MEDP at 1.86% in Q3 2025, 1.09% in Q2 2025, and 0.59% in Q1 2025.